TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 160 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,299,000 | -4.8% | 30,007 | +2.7% | 1.50% | -5.8% |
| Q4 2015 | $4,514,000 | -71.2% | 29,205 | -73.4% | 1.60% | -71.0% |
| Q3 2015 | $15,673,000 | +7.3% | 109,687 | +7.9% | 5.51% | +26.0% |
| Q2 2015 | $14,611,000 | +34.6% | 101,681 | +32.1% | 4.38% | +23.9% |
| Q1 2015 | $10,853,000 | -7.9% | 76,957 | -3.3% | 3.53% | -24.1% |
| Q4 2014 | $11,790,000 | +20.8% | 79,557 | +25.4% | 4.65% | +28.0% |
| Q3 2014 | $9,758,000 | -25.3% | 63,420 | -31.9% | 3.63% | -42.1% |
| Q2 2014 | $13,061,000 | +25.9% | 93,133 | -0.3% | 6.27% | +37.9% |
| Q1 2014 | $10,371,000 | +26.1% | 93,433 | +12.4% | 4.54% | +20.5% |
| Q4 2013 | $8,222,000 | +25.3% | 83,132 | -3.7% | 3.77% | -3.3% |
| Q3 2013 | $6,560,000 | +116.1% | 86,310 | +58.9% | 3.90% | +114.0% |
| Q2 2013 | $3,036,000 | – | 54,310 | – | 1.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |